Provided by Tiger Trade Technology Pte. Ltd.

LifeMD Inc.

4.19
-0.2500-5.63%
Volume:961.23K
Turnover:4.05M
Market Cap:201.01M
PE:16.76
High:4.41
Open:4.38
Low:4.10
Close:4.44
52wk High:15.84
52wk Low:2.56
Shares:47.97M
Float Shares:38.44M
Volume Ratio:0.66
T/O Rate:2.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.2500
EPS(LYR):0.2492
ROE:-131.16%
ROA:-6.54%
PB:8.68
PE(LYR):16.81

Loading ...

Lake Street Reaffirms Their Buy Rating on LifeMD (LFMD)

TIPRANKS
·
Nov 17, 2025

BRIEF-LifeMd To Offer Market-Leading Pricing For Glp-1 Medications Wegovy And Ozempic In Continued Collaboration With Novo Nordisk

Reuters
·
Nov 17, 2025

LifeMD Inc - Offers Glp-1 Medications at $199 per Month

THOMSON REUTERS
·
Nov 17, 2025

LifeMD® to Offer Market-Leading Pricing for Glp-1 Medications Wegovy® and Ozempic® in Continued Collaboration With Novo Nordisk

THOMSON REUTERS
·
Nov 17, 2025

Top News Today: Stocks Mixed as AI Selloff Slows

Dow Jones
·
Nov 15, 2025

BRIEF-LifeMD Files Non-Timely 10-Q With US SEC

Reuters
·
Nov 13, 2025

LifeMD Inc Files Non-Timely 10-Q With U.S. SEC

THOMSON REUTERS
·
Nov 13, 2025

LifeMD - Identifies About $4.6 Mln in Cumulative Over Recognition of Revenue, With Offsetting Amounts in Related Balance Sheet Accounts

THOMSON REUTERS
·
Nov 13, 2025

LifeMD Inc - Evaluating Potential Impact on Internal Control Over Financial Reporting

THOMSON REUTERS
·
Nov 13, 2025

LifeMD Delays Quarterly Financial Report Over Revenue Recognition Errors

Reuters
·
Nov 13, 2025

LifeMD to Join BTIG Digital Health Forum Panel

Reuters
·
Nov 10, 2025

BRIEF-LifeMD Expects To File Form 12B-25, Notifying US SEC Of Late Filing Of Form 10-Q For Period Ended September 30, 2025

Reuters
·
Nov 06, 2025

LifeMD Inc - Expects to File Form 12B-25, Notifying U.S. SEC of Late Filing of Form 10-Q for Period Ended September 30, 2025

THOMSON REUTERS
·
Nov 06, 2025

LifeMD Inc. to Announce Third Quarter 2025 Results

Reuters
·
Nov 06, 2025

LifeMD Inc expected to post a loss of 5 cents a share - Earnings Preview

Reuters
·
Nov 05, 2025

LifeMD Sells Majority Interest in WorkSimpli Software

MT Newswires Live
·
Nov 05, 2025

LifeMD Inc - Sellers Eligible for up to $28 Mln Additional Cash Upon Worksimpli Achieving Targets Over Next Three Years

THOMSON REUTERS
·
Nov 04, 2025

LifeMD Inc - Worksimpli Valued at $65 Mln in Deal

THOMSON REUTERS
·
Nov 04, 2025

LifeMD Divests Majority Interest in Worksimpli Software, Positioning Company as a Pure-Play Virtual Care and Pharmacy Platform

THOMSON REUTERS
·
Nov 04, 2025

LifeMD Inc. Faces Class Action Lawsuit Alleging Securities Fraud Between May and August 2025

Reuters
·
Oct 17, 2025